Context Capital Management’s Zura Bio ZURA Stock Holding History

Context Capital Management’s Portfolio ZURA Stock Details ZURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-100,000	Closed	-$1.02M	–	352
2022 Q4	$1.02M	Hold	100,000	–	–	0.07%	202
2022 Q3	$1.01M	Hold	100,000	–	–	0.07%	282
2022 Q2	$995K	Hold	100,000	–	–	0.07%	296
2022 Q1	$991K	Buy	+100,000	New	+$985K	0.06%	329

Other funds holding ZURA

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SAMU

SONA Asset Management (US) New York $4.74B AUM 11.18% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Context Capital Management's ZURA Position: Q1 2023 in Review

Context Capital Management sold out of Zura Bio (ZURA) in Q1 2023, closing a stake of 100,000 shares — an estimated $1.02M sold.

Context Capital Management first reported a position in ZURA in Q1 2022 and held it in 4 quarters. The position peaked at $1.02M in Q4 2022. 3 funds tracked by Wall St. Rank hold ZURA as of Q1 2023.

Context Capital Management reported no remaining Zura Bio position as of Q1 2023 after selling out during the quarter.
Context Capital Management sold 100,000 Zura Bio shares in Q1 2023, an estimated $1.02M.
Context Capital Management first reported a position in Zura Bio in Q1 2022 and held it in 4 quarters.
Context Capital Management's Zura Bio position peaked at $1.02M in Q4 2022.
3 funds tracked by Wall St. Rank held Zura Bio as of Q1 2023.

Based on Context Capital Management's 13F filing for Q1 2023, filed 8 May 2023.